TECX FY 2022 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena

TECXTectonic Therapeutic, Inc.

$635M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$33M

Net Income

-$32M

EPS (Diluted)

$-29.05

Cash Flow

Operating Cash Flow

-$97M

Free Cash Flow

-$97M

Stock-Based Comp.

$1,119

Balance Sheet

Total Assets

$47M

Total Liabilities

$93M

Stockholders' Equity

-$46M

Cash & Equivalents

$36M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$33M	-$16M	-110.3%
Net Income	-$32M	-$9M	-260.5%